alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               JUN-30-1999
<CASH>                                      10,087,261
<SECURITIES>                                 1,253,795
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                            11,919,593
<PP&E>                                       4,164,102
<DEPRECIATION>                                 855,072
<TOTAL-ASSETS>                              15,301,223
<CURRENT-LIABILITIES>                        2,235,441
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        10,731
<OTHER-SE>                                  12,425,422
<TOTAL-LIABILITY-AND-EQUITY>                15,301,223
<SALES>                                              0
<TOTAL-REVENUES>                             3,643,057
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                             7,759,090
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              59,730
<INCOME-PRETAX>                            (3,872,022)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (3,872,022)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (3,872,022)
<EPS-BASIC>                                      (.37)
<EPS-DILUTED>                                    (.37)


</TABLE>
EXECUTIVE OFFICE OF THE PRESIDENT

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

WASHINGTON, D.C. 20508

February 4, 2019

RE: Product Exclusion Request Number: USTR-2018-0025-3437

Stanley Electric Co, Ltd:

The purpose of this letter is to inform you that the product exclusion request referenced 

above has been denied. As you are aware, USTR published a Federal Register notice (83 FR 

28710) on June 20, 2018, that announced the Trade Representative’s determination to impose an 

additional duty of 25 percent on certain products from China. On July 11, 2018, the Trade 

Representative published a Federal Register notice (83 FR 32181) which announced that a 

process had been established under which interested persons could request that products falling 

within a covered HTSUS subheading be excluded from the additional duties announced on June 

20.

Your request was reviewed in accordance with the factors and procedures set forth in 

Section B(1) of the July 11 notice. Based on that review, and after careful consideration, your 

request was denied because the request failed to show that the imposition of additional duties on 

the particular product would cause severe economic harm to you or other U.S. interests.

Because USTR will grant exclusion requests on a product specific basis, you may still 

benefit from a product exclusion if a similar product is granted an exclusion. Products for which 

an exclusion has been granted will be periodically announced on the USTR website. Product 

exclusions will become legally effective once published in the Federal Register. 

Sincerely,

Stephen P. Vaughn

General Counsel
```

[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[S. 4388 Introduced in Senate (IS)]

<DOC>

117th CONGRESS
  2d Session
                                S. 4388

To amend title 10, United States Code, to waive cost-sharing under the 
TRICARE program for three mental health outpatient visits per year, and 
                          for other purposes.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             June 14, 2022

Mr. Ossoff (for himself and Mr. Cramer) introduced the following bill; 
  which was read twice and referred to the Committee on Armed Services

_______________________________________________________________________

                                 A BILL

 
To amend title 10, United States Code, to waive cost-sharing under the 
TRICARE program for three mental health outpatient visits per year, and 
                          for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Military Families Mental Health 
Services Act''.

SEC. 2. WAIVER OF COST-SHARING FOR THREE MENTAL HEALTH OUTPATIENT 
              VISITS UNDER THE TRICARE PROGRAM.

    (a) TRICARE Select.--Section 1075(c) of title 10, United States 
Code, is amended by adding at the end the following new paragraph:
            ``(4) Consistent with other provisions of this chapter and 
        under requirements to be prescribed by the Secretary, the 
        Secretary may waive cost-sharing requirements for the first 
        three outpatient mental health visits of a beneficiary each 
        year.''.
    (b) TRICARE Prime.--Section 1075a(a) of such title is amended by 
adding at the end the following new paragraph:
            ``(4) Consistent with other provisions of this chapter and 
        under requirements to be prescribed by the Secretary, the 
        Secretary may waive cost-sharing requirements for the first 
        three outpatient mental health visits of a beneficiary each 
        year.''.
                                 <all>
```
EX-10.2






BILL OF SALE




KNOW ALL BY THESE PRESENTS, THAT CHELTENHAM YORK ROAD NURSING AND REHABILITATION CENTER INC.,
a Pennsylvania nonprofit corporation (“Seller”), in consideration of the Purchase Price (as
defined in that certain Agreement of Purchase and Sale dated June 14, 2011 (the
"Agreement”), between Seller and G&E HC REIT II Cheltenham York SNF, L.P., a Delaware
limited partnership (“Purchaser”) paid to Seller, the receipt and sufficiency of which is
hereby acknowledged, has agreed pursuant to the Agreement, to sell, assign, transfer, convey, set
over and deliver to Purchaser, and by these presents and pursuant to the Agreement does hereby
sell, assign, transfer, convey, set over and deliver unto Purchaser the Tangible Personal Property
and Business Records (as defined in the Agreement); and Purchaser hereby accepts such assignment.



This Bill of Sale shall be governed by and construed in accordance with the laws of the
Commonwealth of Pennsylvania, without regard to conflicts of laws provisions.



(Signature Page Follows)





1






IN WITNESS WHEREOF, and intending to be legally bound hereby, Seller and Purchaser have
executed and delivered this Bill of Sale as of 11:59 p.m. on the 30th day of June,
2011.



SELLER:



CHELTENHAM YORK ROAD NURSING AND


REHABILITATION CENTER INC., a Pennsylvania nonprofit corporation



By: /s/ Don Levesque

Name: Don Levesque

Title: Treasurer







PURCHASER:



G&E HC REIT II CHELTENHAM YORK SNF, L.P.,



a Delaware limited partnership



By: G&E HC REIT II Philadelphia SNF Portfolio SPE General Partner, LLC,


a Delaware limited liability company, its general partner



By: /s/ Shannon K S Johnson

Name: Shannon K S Johnson

Title: Authorized Signatory





2
EXECUTIVE OFFICE OF THE PRESIDENT

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

WASHINGTON, D.C. 20508

December 28, 2018

RE: Product Exclusion Request Number: USTR-2018-0025-3373

Enerpac:

I am pleased to notify you that the United States Trade Representative has determined to 

grant the above-referenced exclusion request submitted pursuant to the notice published at 83 FR 

32181 (‘July 11 notice’). The exclusion determination is set out in a formal notice which has 

been submitted to Office of the Federal Register for publication (‘the exclusion notice’). A prepublication version of the exclusion notice has been posted on the USTR website, at 

https://ustr.gov/sites/default/files/enforcement/301Investigations/12.21.18_Notice_of_Product_E

xclusions.pdf.

The scope of the exclusion is governed by the formal HTSUS language in the annex to 

the product exclusion notice, and not by the product descriptions set out in any particular request 

for exclusion. An exclusion in response to your request has been granted by excluding from the 

additional tariffs the 10-digit HTSUS subheading under which your request was filed. 

In accordance with the July 11 notice, the exclusion applies as of the July 6, 2018 

effective date of the tariff action, and will extend for one year after the exclusion notice is 

published in the Federal Register. As stated in the exclusion notice, U.S. Customs and Border 

Protection will issue additional instructions on entry guidance and implementation.

Sincerely,

Stephen P. Vaughn

General Counsel
EXECUTIVE OFFICE OF THE PRESIDENT

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

WASHINGTON, D.C. 20508

March 15, 2019

RE: Product Exclusion Request Number: USTR-2018-0025-4972

Apergy ESP Systems, LLC:

The purpose of this letter is to inform you that the product exclusion request referenced 

above has been denied. As you are aware, USTR published a Federal Register notice (83 FR 

28710) on June 20, 2018, that announced the Trade Representative’s determination to impose an 

additional duty of 25 percent on certain products from China. On July 11, 2018, the Trade 

Representative published a Federal Register notice (83 FR 32181) which announced that a 

process had been established under which interested persons could request that products falling 

within a covered HTSUS subheading be excluded from the additional duties announced on June 

20.

Your request was reviewed in accordance with the factors and procedures set forth in 

Section B(1) of the July 11 notice. Based on that review, and after careful consideration, your 

request was denied because the request failed to show that the imposition of additional duties on 

the particular product would cause severe economic harm to you or other U.S. interests.

Because USTR will grant exclusion requests on a product specific basis, you may still 

benefit from a product exclusion if a similar product is granted an exclusion. Products for which 

an exclusion has been granted will be periodically announced on the USTR website. Product 

exclusions will become legally effective once published in the Federal Register. 

Sincerely,

Stephen P. Vaughn

General Counsel
Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by
reference in the following Registration Statements:

(1) Registration Statement Number 33-60730 on Form S-8 filed March 31, 1993,

(2) Registration Statement Number 333-27459 on Form S-8 filed May 20, 1997,

(3) Registration Statement Number 333-67033 on Form S-8 filed November 10, 1998,

(4) Registration Statement Number 333-87996 on Form S-8 filed May 10, 2002,

(5) Registration Statement Number 333-89862 on Form S-4/A filed October 24, 2002,

(6) Registration Statement Number 333-105081 on Form S-8 filed May 8, 2003,

(7) Registration Statement Number 333-109353 on Form S-4 filed October 1, 2003,

(8) Registration Statement Number 333-123218 on Form S-3/A filed May 16, 2005,

(9) Registration Statement Number 333-129636 on Form S-3 filed November 10, 2005,

(10) Registration Statement Number 333-129632 on Form S-8 filed November 10, 2005,

(11) Registration Statement Number 333-138302 on Form S-3 filed October 30, 2006,

(12) Registration Statement Number 333-140400 on Form S-3 filed February 2, 2007, and

(13) Registration Statement Number 333-142883 on Form S-4/A filed July 3, 2007,

of our reports dated February 25, 2008, with respect to the consolidated financial statements and financial statement schedule of Jarden Corporation and the effectiveness of internal control over financial
reporting of Jarden Corporation, included in this Annual Report (Form 10-K) for the year ended December 31, 2007.



|                   |  |  |  |                      
|------------------ |  |  |  | ---------------------
|                   |  |  |  | /s/ Ernst & Young LLP
|New York, New York |  |  |  |                      
|February 25, 2008  |  |  |  |
##### 



Exhibit 31.1
 CERTIFICATION PURSUANT TO
SECTION 13a-15 OF THE SECURITIES AND EXCHANGE ACT OF 1934
AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
  1.
    
    I have reviewed this annual report on Form 10-K/A of U.S. Can Corporation;2.
    
    Based on my knowledge, this annual report does not contain any untrue statement
of a material fact or omit to state a material fact necessary to make the statements
made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this report;3.
    
    Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the registrant as of, and
for, the periods presented in this report;4.
    
    The registrants other certifying officers and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in Exchange
Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:
 (a)
    
    Designed such disclosure controls and procedures, or caused such
disclosure controls and procedures to be designed under our supervision, to
ensure that material information relating to the registrant, including its
consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this report is being
prepared;(b)
    
    Evaluated the effectiveness of the registrants disclosure controls and
procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of the
period covered by this report based on such evaluation; and(c)
    
    Disclosed in this report any change in the registrants internal control
over financial reporting that occurred during the registrants most recent fiscal quarter
(the registrants fourth fiscal quarter in the case of an annual report) that has
materially affected, or is reasonably likely to materially affect, the registrants
internal control over financial reporting; and
 5.
    
    The registrants other certifying officers and I have disclosed, based on our most
recent evaluation of internal control over financial reporting, to the registrants
auditors and the audit committee of the registrants board of directors (or persons
performing the equivalent functions);
 (a)
    
    All significant deficiencies and material weaknesses in
the design or operation of internal control over financial reporting which
are reasonably likely to adversely affect the registrants ability to
record, process, summarize and report financial information; and(b)
    
    Any fraud, whether or not material, that involves
management or other employees who have a significant role in the
registrants internal control over financial reporting.
 Date: October 4, 2005/s/ Philip R. Mengel

Philip R. MengelChief Executive Officer
Exhibit 10.11



ACTION BY UNANIMOUS WRITTEN CONSENT

OF THE BOARD OF DIRECTORS

OF

VERTEL CORPORATION

a California Corporation



August 14, 2002



In accordance
with Section 307(b) of the California Corporations Code and the Bylaws of Vertel Corporation (the Company), the undersigned, constituting all of the directors of the Company, hereby take the following actions and adopt the following
resolutions by unanimous written consent without a meeting, effective for all purposes as of the date first written above:



Restructuring and Renewal of Suite 700, 21300 Victory Blvd., Woodland Hills CA Lease



WHEREAS, there has been discussion at previous Board meetings
relating to the Companys Headquarters lease at 21300 Victory Blvd., Suite 700, Woodland Hills CA and a proposal has been negotiated with 21300 Victory Boulevard, LLC (the landlord) as follows:



Effective July 1, 2002, the Company will be released from its
monthly base rental obligation of $47,335.20 (21,516 square feet at $2.20 per square foot) under the existing lease which expires January 19, 2003, provided the Company signs a three-year extension to its existing lease, effective July 1, 2002,
for 9,052 square feet at an initial rental of $2.25 per square foot ($20,367 per month). The base rental will increase to $2.32 per square foot, effective January 1, 2004. Additionally, the landlord will reduce the July 2002 rental obligation by 50%
as an inducement for the Company to enter into the extension.



The proposed arrangement allows the Company to save approximately $180,000 in cash and rent expense by restructuring the current lease prior to its expiration. To achieve this, the Company must commit to a three-year extension to
June 30, 2005 (only 30 months from the expiration of the existing lease). The space occupied will be reduced by approximately 58%.



NOW THEREFORE, BE IT RESOLVED, that the Company extend its lease for Suite 700, 21300 Victory Boulevard, Woodland Hills CA, substantially
on the terms outlined above.



Omnibus
Provision



RESOLVED, FURTHER, that the
officers of the Company, each of them with full authority to act without the others, are authorized and directed to do or cause to be done any and all such further acts and things and to execute and deliver any and all such additional documents as
they may deem necessary or appropriate in order to carry into effect the purposes and intent of the foregoing resolutions.



This action may be signed in one or more counterparts, each of which shall be deemed an original and all of which shall constitute one
instrument. This action was executed effective as of the date first set forth above.







|Marc E. Maassen      |  |  |  | Robert T. Flood               
|-------------------- |  |  |  | ------------------------------
|                    
|Cyrus D. Irani       |  |  |  | Hai-Perng Kuo, a.k.a. Alex Kuo
|                    
|Michael A. Sternberg |  |  |  |                               



[Signature Page to Board Consent of Vertel Corporation

Re: Amendment To Suite 700, 21300 Victory Boulevard,
Woodland Hills CA Lease]
EXECUTIVE OFFICE OF THE PRESIDENT

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

WASHINGTON, D.C. 20508

February 4, 2019

RE: Product Exclusion Request Number: USTR-2018-0025-4991

OMRON Management Center of America, Inc:

The purpose of this letter is to inform you that the product exclusion request referenced 

above has been denied. As you are aware, USTR published a Federal Register notice (83 FR 

28710) on June 20, 2018, that announced the Trade Representative’s determination to impose an 

additional duty of 25 percent on certain products from China. On July 11, 2018, the Trade 

Representative published a Federal Register notice (83 FR 32181) which announced that a 

process had been established under which interested persons could request that products falling 

within a covered HTSUS subheading be excluded from the additional duties announced on June 

20.

Your request was reviewed in accordance with the factors and procedures set forth in 

Section B(1) of the July 11 notice. Based on that review, and after careful consideration, your 

request was denied because the request failed to show that the imposition of additional duties on 

the particular product would cause severe economic harm to you or other U.S. interests.

Because USTR will grant exclusion requests on a product specific basis, you may still 

benefit from a product exclusion if a similar product is granted an exclusion. Products for which 

an exclusion has been granted will be periodically announced on the USTR website. Product 

exclusions will become legally effective once published in the Federal Register. 

Sincerely,

Stephen P. Vaughn

General Counsel
|EXHIBIT 12
|----------

|PRIME MEDICAL SERVICES, INC. AND SUBSIDIARIES
                                        COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES
                                      FOR THE YEARS ENDED DECEMBER 31, 2003, 2002, 2001, 2000 AND 1999
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

($ in thousands)

|                                         | Years Ended December 31,
|---------------------------------------- | ------------------------
|
|Income (loss) before income taxes        |                         
|and after minority interests             |                         
|Undistributed equity income              |                         
|Minority interest income of subsidiaries |                         
|with fixed charges                       |                         
|                                         |                         
|Adjusted earnings                        |                         
|                                         |                         
|Interest on debt                         |                         
|Debt issuance costs                      |                         
|                                         |                         
|Total fixed charges                      |                         
|                                         |                         
|Total available earnings                 |                         
|before fixed charges                     |                         
|                                         |                         
|Ratio                                    |                         
|                                         |
**Exhibit 32.1**

**STATEMENTOF CHIEF EXECUTIVE OFFICERPURSUANT TO 18 U.S.C. SECTION 1350**

Inconnection with the Quarterly Report on Form 10-Q for the periodended March 31, 2006 (the “Form 10-Q”) of Cardinal FinancialCorporation, I, Bernard H. Clineburg, Chairman and Chief Executive Officer,hereby certify pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(a)           the Form 10-Q fullycomplies with the requirements of Section 13(a) of the SecuritiesExchange Act of 1934, as amended; and

(b)           the information contained in the Form 10-Qfairly presents, in all material respects, the consolidated financial conditionand results of operations of the Company and its subsidiaries as of, and for,the periods presented in the Form 10-Q.
| Date: May 9, 2006 |   | /s/ Bernard H. Clineburg             |
|------------------------|--------|--------------------------------------|
|                   |   | Bernard H. Clineburg                 |
|                   |   | Chairman and Chief Executive Officer |

 

----